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Abstract
Processing of Okazaki fragments to complete lagging-strand DNA synthesis requires coordination
among several proteins. RNA primers and DNA synthesised by DNA polymerase  ? are displaced
by DNA polymerase  ? to create bifurcated nucleic acid structures known as 5ᓉ-flaps. These 5ᓉ-
flaps are removed by Flap Endonuclease 1 (FEN), a structure-specific nuclease whose divalent
metal-ion-dependent phosphodiesterase activity cleaves 5ᓉ-flaps with exquisite specificity. FENs
are paradigms for the 5ᓉ nuclease superfamily, whose members perform a wide variety of roles in
nucleic acid metabolism using a similar nuclease core domain that displays common biochemical
properties and structural features. A detailed review of FEN structure is undertaken to show how
DNA substrate recognition occurs and how FEN achieves cleavage at a single phosphate diester.
A proposed double nucleotide unpairing trap (DoNUT) is discussed with regards to FEN and has
relevance to the wider 5ᓉ-nuclease superfamily. The homotrimeric proliferating cell nuclear
antigen protein (PCNA) coordinates the actions of DNA polymerase, FEN and DNA ligase by
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facilitating the hand-off intermediates between each protein during Okazaki fragment maturation
to maximise through-put and minimise consequences of intermediates being released into the
wider cellular environment. FEN has numerous partner proteins that modulate and control its
action during DNA replication and is also controlled by several post-translational modification
events, all acting in concert to maintain precise and appropriate cleavage of Okazaki fragment
intermediates during DNA replication.
Keywords
Okazaki fragment maturation; Lagging-strand DNA replication; Double nucleotide unpairing;
Structure-specific nuclease; Disorder-order transition
16.1 Introduction
Unlike leading-strand DNA replication, lagging-strand DNA is synthesised discontinuously
as the replication fork moves in the opposite direction to the polymerase. As the replication
fork progresses, newly exposed DNA on the lagging strand is continuously primed by
primase/pol  ? then extended by pol  ? with the assistance of PCNA. These segments of DNA
on the lagging-strand are known as Okazaki fragments, and it is estimated that human DNA
replication generates ᙺ50 million per cell cycle (Burgers 2009). To form a continuous piece
of DNA, the RNA primer, and possibly the DNA laid down by pol  ?, must be removed,
with DNA being subsequently ligated to complete Okazaki fragment maturation (Fig.
16.1a). Initial experiments aimed at reconstituting the DNA replication machinery in vitro
using fractionated nuclear extracts identified a maturation factor (MF1) necessary for the
completion of lagging-strand DNA replication (Waga et al. 1994). This maturation factor
was later renamed Flap Endonuclease due to the enzyme's preference to cleave bifurcated
DNA structures with displaced 5ᓉ-single-stranded DNA flaps (Fig. 16.1b–d) (Harrington
and Lieber 1994). Flap endonucleases (FENs), which are present across all domains of life,
are divalent metal ion-dependent nucleases, whose phosphodiesterase activity enhances the
hydrolysis rate of targeted phosphodiester bonds at least ᙺ1017 fold (Tomlinson et al. 2010).
FENs possess a single active site that can perform both endo-and exonucleolytic cleavages.
Furthermore, FENs are considered prototypical members of the 5ᓉ-nuclease superfamily,
which includes enzymes with diverse DNA processing activities such as EXO1, XPG and
GEN1 (Finger and Shen 2010; Tomlinson et al. 2010; Grasby et al. 2011), as well as the 5ᓉ-
exoribonucleases Xrn1 and Rat1 (Solinger et al. 1999; Yang 2010).
Current paradigms of eukaryotic DNA replication are based mainly on studies in yeast
(Burgers 2009). FENs were once thought to be solely responsible for cleavage of flaps of
any length in vivo, but studies identified two additional proteins involved in yeast Okazaki
fragment maturation – Pif1 and Dna2 (Budd and Campbell 1997; Budd et al. 2006). Pif1, a
member of the IB helicase superfamily (Bochman et al. 2010), has been shown to increase
the efficiency of pol  ? strand displacement synthesis, thereby resulting in long (>30
nucleotides) 5ᓉ ssDNA flaps. Exposure of 30 or more nucleotides of ssDNA recruits
Replication Protein A (RPA; ssDNA binding protein), resulting in a 5ᓉ-flap-ssDNA-RPA
complex that is refractory to FEN1 cleavage. To remove these RPA coated flaps, the RPA-
activated Dna2 nuclease/helicase is recruited to imprecisely cleave the long flap, thereby
creating a short flap that is then processed by FEN1 (Kang et al. 2010). The relevance of this
yeast “two-step” Okazaki fragment maturation model to mammalian systems remains
unclear. Nonetheless, both short and long flap pathways require the ability of FEN to cleave
with exquisite precision to create a product that is a substrate for DNA ligase. Primers that
are incorrectly processed or not removed by FEN would create gaps or overlaps,
respectively, resulting in genomic instability, as seen in studies of budding and fission yeast
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lacking Rad27/Rad2 (FEN1 homologues in Saccharomyces cerevisiae and
Schizosaccharomyces pombe, respectively) (Johnson et al. 1995; Reagan et al. 1995), which
display severe mutator phenotypes (Liu et al. 2004; Navarro et al. 2007).
The importance of FEN is further highlighted in higher eukaryotes, where homozygous
deletion of the fen1 gene (fen1−/−) is embryonically lethal in mice (Larsen et al. 2003),
indicating that FEN1 is absolutely essential in mammals. FEN1 is expressed in all
proliferative tissues in humans, including cancers (Kim et al. 2000; Warbrick et al. 1998).
FEN1 expression levels in normal tissue are correlated with proliferative capacity. In
addition, FEN1 over-expression in human cancers has been linked to tumour aggressiveness
(Finger and Shen 2010); for this reason, the chemotherapeutic potential of FEN1 inhibitors
has been investigated (Tumey et al. 2004, 2005). Furthermore, mutations that decrease
expression levels or alter FEN1 biochemical properties predispose humans and mice to
cancers (Kucherlapati et al. 2002; Larsen et al. 2008; Zheng et al. 2007b). Thus, a paradox
of FEN activity emerges: optimal FEN1 activity is essential to prevent cancer, but
overabundance or impaired function of FEN1 can promote cancer by increasing the
efficiency of DNA replication and repair or reducing fidelity of DNA replication
respectively.
An area of controversy regarding FENs is how the enzyme is able to precisely cleave at a
single phosphate diester to create a ligatable nick based solely upon the structure instead of
the sequence of the DNA. Early studies established that prokaryotic and eukaryotic FENs
recognize the structure of bifurcated 5ᓉ-flaps rather than sequence (Harrington and Lieber
1995; Lyamichev et al. 1993), but controversy as to how this was accomplished quickly
emerged. Dahlberg and co-workers suggested that specificity was achieved by threading the
5ᓉ-flap through a hole in the FEN protein. Subsequent biochemical studies on mammalian
FENs supported this proposal and suggested that these enzymes thread the 5ᓉ flap through a
hole in the protein until it encounters the dsDNA, whereupon cleavage occurs (Murante et
al. 1995). Structural studies with bacteriophage T5 FEN (T5FEN) revealed a helical
archway above the active site whose dimensions could only accommodate ssDNA (Ceska et
al. 1996), lending support to threading models. Further biochemical and structural work
subsequently suggested instead that the helical arch was actually used to clamp onto 5ᓉ-flap
ssDNA at the 5ᓉ-terminus and to then track along the flap until dsDNA was encountered and
subsequently cleaved (Bornarth et al. 1999; Chapados et al. 2004). Alternatively, studies
using the E. coli FEN homologue led Joyce and colleagues to suggest that FENs initially
recognize the dsDNA portion of 5ᓉ-flap substrates and then, thread the 5ᓉ-flap DNA (Xu et
al. 2001). More recent evidence from several groups suggests that the latter model is a better
mechanistic description of eukaryotic FENs (Finger et al. 2009; Gloor et al. 2010; Hohl et
al. 2007; Stewart et al. 2009). Furthermore, X-ray crystallographic studies of enzyme-
substrate and enzyme-product complexes of human FEN1 (hFEN1) have shed light on how
FENs identify their substrate and select the scissile phosphate (Tsutakawa et al. 2011). Here,
we review both biochemical and structural aspects of FEN1 that give rise to a structure-
specific nuclease with exquisite scissile phosphate diester selectivity, and then, discuss how
this protein is assisted and regulated in vivo by sub-cellular localization, protein interaction
partners, and post-translational modification.
16.2 Biochemical Activity
FENs cleave a large range of substrates in vitro with a 5ᓉ to 3ᓉ polarity both endo-and exo-
nucleolytically (Fig. 16.1b–i) (Nazarkina et al. 2008; Shen et al. 2005). The divalent metal
ion-dependent phosphodiesterase activity of FENs exclusively generates 5ᓉ-phosphate
monoester and 3ᓉ-hydroxyl products (Pickering et al. 1999). However, the catalytic
efficiency on each type of substrate structure varies greatly. In addition to DNA replication,
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FENs have also been implicated in other DNA metabolic pathways due to the ability to
observe activities with certain substrates (Zheng et al. 2011b).
Eukaryotic and archaeal FENs prefer substrates with two dsDNA regions (Fig. 16.1b–e), but
substrates having only a single dsDNA region of at least 12 base pairs can be cleaved as
well, albeit weakly (Fig. 16.1f–i). Single 5ᓉ-flap substrates (Fig. 16.1d) were initially
thought to be the preferred substrate of FENs (Harrington and Lieber 1995; Lyamichev et al.
1999), but 5ᓉ-flap and EXO substrates also having a single nucleotide 3ᓉ-flap (i.e., a double-
flap substrate) were later shown to be the preferred substrates for eukaryotic FENs (Fig.
16.1b,c) for three reasons. Substrates bearing 3ᓉ-flaps have lower apparent KDs (Friedrich-
Heineken and Hubscher 2004; Kao et al. 2002), are cleaved with greater efficiency than
their single-flap cognates, and are cleaved exclusively at the phosphate diester between the
first and second nucleotide of the downstream duplex. Importantly, this increased precision
results in all dsDNA product being ligatable (Fig. 16.2a) (Finger et al. 2009; Kao et al.
2002). With single-flap substrates, cleavage is less efficient and predominantly occurs at the
dsDNA-ssDNA flap junction, but to a lesser extent also one nucleotide into the downstream
duplex (Fig. 16.2b) (Finger et al. 2009; Kao et al. 2002). The minor cleavage product results
in a 1-nt gap that would require post-replication repair mechanisms to fill in and close the
gap (Chapados et al. 2004; Finger and Shen 2010). Lower organism FENs, such as those
from the T4 and T5 bacteriophages, do not possess a 3ᓉ-flap binding pocket (Friedrich-
Heineken and Hubscher 2004; Shen et al. 1998). Thus, FENs from higher organisms have
evolved such a feature to ensure that cleavage results in immediately ligatable nicks,
avoiding the need for initiation of DNA repair mechanisms.
The substrates used in vitro are commonly designed to exclusively form a 5ᓉ-flap of a
known length, with or without a single nt 3ᓉ-flap. These types of flap substrates are referred
to as static double-flap and single-flap substrates, respectively (Fig. 16.2c,d), and are
prepared either as tri-, bi-, or uni-molecular constructs (Fig. 16.1j). The ‘template strand’
oligonucleotide corresponds to the lagging-strand template in vivo. The strand that base
pairs with the template to form the upstream duplex region is equivalent to the nascently
synthesized pol  ? DNA, whereas the strand that anneals to form the downstream dsDNA
corresponds to pol  ? and/or pol  ? synthesized DNA of the previous Okazaki fragment
depending on the extent of strand displacement synthesis (Fig. 16.1j–l) and assuming that
RNaseH has already removed all but the last nucleotide of the RNA primer (Chon et al.
2009; Mesiet-Cladiere et al. 2007; Qiu et al. 1999). In vivo pol  ? and pol  ? use the same
template, so the sequences they synthesise should be identical. Thus, the 5ᓉ-flap structures
generated in vivo are ‘equilibrating’ double-flap substrates (Liu et al. 2004); as such,
overlapping sequences can form multiple structures of varying 5ᓉ and 3ᓉ flap lengths by a
mechanism analogous to Holliday junction migration (Fig. 16.2e). Model ‘equilibrating’
double flap structures are cleaved at a single phosphate diester in a manner analogous to the
cleavage of a static double-flap substrate (i.e., one nucleotide into the downstream duplex)
(Kao et al. 2002). The 3ᓉ-flap in the static and equilibrating double-flap substrates
corresponds to the last nucleotide added by pol  ? during strand displacement synthesis (Figs.
16.1a and 16.2e). Thus, FENs have evolved to recognize the last nucleotide added by pol  ?
and to identify the scissile phosphate accordingly. In addition to increased specificity, the
3ᓉ-flap augments “enzyme commitment” to the forward reaction by increasing first-order
rates of reaction after initial enzyme substrate complex formation (Fig. 16.2f) (i.e., kCC ᚩ
koff) (Finger et al. 2009). In fact, the catalytic efficiency of FEN1 on a static double flap
substrate approaches enzyme:substrate association rates in solution. Therefore, FEN
reactions with static double flap substrates may be diffusion controlled under conditions
whereby substrate is limiting ([E] < [S] < KM; kcat/KM conditions), implying that the
enzyme has reached catalytic perfection (Sengerova et al. 2010).
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Under saturating multiple turnover (MT) conditions ([S]> > KM > > [E]), the enzyme is rate
limited by enzyme product release as single turnover (ST) rates of hydrolysis are faster than
MT rates (Fig. 16.2f) (Finger et al. 2009; Williams et al. 2007). On double-flap substrates,
FENs produce two products (denoted P and Q), which with a double-flap substrate would be
nicked dsDNA product (Q) and a small ssDNA fragment (P). Product inhibition studies have
deduced that the ssDNA product (P) is instantaneously released after cleavage or released
much faster than the dsDNA product, whereas the dsDNA product (Q) is retained (Finger et
al. 2009). Thus, release of the dsDNA product is rate limiting in vitro under MT conditions
(Fig. 16.2f). The fact that FENs hold onto the dsDNA product is similar to the observation
that many DNA metabolic enzymes chaperone their potentially toxic repair intermediates
(Parikh et al. 1999). Furthermore, in FEN1-product DNA crystals, only electron density for
the hFEN1-dsDNA product (Q) and not for the ssDNA flap (P) was observed, consistent
with FEN retaining only the dsDNA product after cleavage (Tsutakawa et al. 2011). Thus,
FENs release the 5ᓉ-flaps ssDNA product, but retain the dsDNA product, which is the
substrate for the next step of Okazaki fragment maturation (i.e., ligation).
Because kcat/KM conditions are likely diffusion controlled and saturating MT conditions are
rate-limited by enzyme product release (Fig. 16.2f), MT measurements of reaction of FENs
are probably not physiologically relevant, as these physical limitations likely do not exist in
the cell (Berg and von Hippel 1985) due to sequestration of FENs to replication forks
(Beattie and Bell 2011) and potential PCNA-mediated handoff (see Chap. 15, this volume)
of replication intermediates between processing proteins (i.e., pol  ? and Ligase I,
respectively) (Chapados et al. 2004; Tsutakawa et al. 2011). A more physiologically relevant
measurement of FEN activity is single-turnover experiments where [S] < KM < <[E]. These
experiments measure the rates of reaction after enzyme-substrate complex formation and
before enzyme product release (Fig. 16.2c). Despite knowing the rate of reaction of the rate-
limiting step under ST conditions, it is difficult to know exactly what is being measured
(e.g., kchem or a physical step in the reaction cycle like kCC/kRCC.) So far, studies of T5FEN
have shown that a physical limitation (e.g., protein, DNA or concerted protein/DNA
conformational change (kCC)) is rate limiting under ST conditions (Fig. 16.2f) (Sengerova et
al. 2010). This is likely to be the case for eukaryotic FENs in vitro as well.
16.3 FEN Structure and Substrate Recognition
16.3.1 Free Protein
Crystal structures of FENs lacking substrate have been solved from a wide variety of
organisms (Ceska et al. 1996; Chapados et al. 2004; Hos field et al. 1998b; Hwang et al.
1998; Mase et al. 2009; Sakurai et al. 2005, 2008). These have revealed a common
architecture among FENs. The nuclease core domains of FENs fold into an  ?/ ? structure
known as a SAM or PIN fold (Fig. 16.3a). Moreover, a mixed twisted  ?-sheet of (usually)
seven-strands is sandwiched between two  ?-helical regions and forms a saddle-like
structure. Two sites for binding dsDNA are on either side of the  ?-sheet. Protruding from the
saddle-like structure is the region called the helical arch or helical clamp that in some crystal
structures is observed as a disordered, flexible loop, and in others is structured as two  ?
helices poised above the active site. The active site of FENs are highly conserved and in
eukaryotic and archaeal FENs, and is characterized by the presence of seven acidic residues
(Lieber 1997; Shen et al. 1998) (Fig. 16.3a) that sequester the divalent metal ions requisite
for catalysis. Consistent with a two metal ion mechanism for phosphate diester hydrolysis
(Yang et al. 2006), these acidic residues in the hFEN1 substrate-free structure hold the
divalent metal ion <4 A apart; however, the occupancy in the crystal structures varies for the
metals (Sakurai et al. 2005). An unusual feature of archaeal and eukaryotic FENs is that
their N-termini are structured and lie close to the active site. If electron density for the N-
terminus can be seen, the sequence starts with Gly2, and thus, N-terminal aminopeptidases
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have removed the initiator methionine during translation (Bradshaw et al. 1998), at least
when expressed as a recombinant protein in E. coli. The observation of structured N-termini
near the active sites of FENs explains why cloning FENs with N-terminal affinity tags
results in proteins that are insoluble (i.e., GST tagged protein) (Zheng and Shen,
unpublished data) or have negligible activity (i.e., His-tags that are cleaved off leaving
additional N-terminal residues) (Grasby and Tainer, unpublished data) (Mase et al. 2009).
This is the reason for the exclusive use of C-terminal affinity tags for recombinant
expression.
16.3.2 Protein-Product and Protein-Substrate Complexes
Comparison of the crystal structures of human FEN1 with product and substrate DNA
revealed an extraordinarily sophisticated dsDNA binding and ssDNA incision mechanism
(Tsutakawa et al. 2011). The proposed model allows FEN to distinguish 5ᓉ-flap structures
from 3ᓉ-flap structures and ssDNA and is biologically elegant in eliminating non-FEN
substrates from inadvertent incision. First, we will discuss structural elements common to
both the enzyme-substrate and enzyme-product complexes with respect to the template and
3ᓉ-flap strand interactions (Fig. 16.1l). Then, we will discuss the differences that exist
between the two complexes at the extreme 5ᓉ-end of the 5ᓉ-flap strand.
The protein-substrate and protein-product complexes show that most of the binding surface
is to the two dsDNA regions. The upstream dsDNA is bent at approximately a 100° angle at
a single phosphate diester relative to the downstream dsDNA. Helix 2 of FEN is wedged
between the basepairs formed at either side of the two-way dsDNA junction (Fig. 16.3c, d).
Thus, an initial recognition mechanism is binding dsDNA containing a junction that can
easily bend at a single phosphate diester. Recognition of the substrate is not mediated
through the 5ᓉ flap DNA strand as would be expected according to the original threading/
clamping and tracking models, but via interactions with the template DNA strand.
Moreover, approximately half of the protein:DNA interface is directed to the template strand
(Fig. 16.4a–d), which corresponds to the parental strand of DNA in replication (Fig. 16.1j).
Part of this interaction is mediated by a potassium ion that that is coordinated to amino acid
peptide carbonyls from a helix-two-turn-helix motif (H2tH), a side chain hydroxyl of a
serine residue, and a phosphate diester from the template DNA (Fig. 16.3b–d, 16.4a–f). In
addition, there are contacts to the 5ᓉ-flap strand near its 3ᓉ-terminus (Fig. 16.4c–d). Another
facet to the dsDNA binding is that the protein-dsDNA interaction surface is not contiguous.
The downstream portion of the template strand departs from the surface of the protein after
the H2tH motif and then, returns to the surface of the protein just before the bend in the
DNA. The template strand enters a groove where the DNA bends sharply, giving rise to the
100° bend at the two-way dsDNA junction. The arc that is formed by the template strand
(template arc) as it leaves and then, returns to the protein surface is used to deliver the 5ᓉ-
flap strand to the proximity of the active site (Fig. 16.4a, b). Moreover, as the downstream
primer strand follows the template strand, it is the 5ᓉ-terminus of the downstream flap strand
that is directed towards the active site. When delivered to the proximity of the active site,
helix 2 and helix 4 residues contact the 5ᓉ-terminal portion of the 5ᓉ-flap strand. However,
the way in which these residues interact with the 5ᓉ-terminal residues of the downstream
primer differs between the enzyme substrate and enzyme product complexes, and will be
dealt with in the next two sections (Tsutakawa et al. 2011).
Despite being base paired to the upstream nucleotides of the template, the only interactions
seen with the 3ᓉ-flap strand are localized to its last three nucleotides. The rest of the
upstream primer strand does not contribute to binding and passively exits from hFEN1 by
following the template DNA (Fig. 16.4c, d). Most of the interactions are to the one
nucleotide 3ᓉ-flap. The 3ᓉ flap binding pocket is constructed by ten amino acid residues,
with most of the protein interaction with the DNA to the sugar-phosphate backbone and the
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3ᓉ-hydroxyl group. None of the interactions are base-specific, as would be expected for a
structure rather than sequence specific nuclease. The 3ᓉ-flap is bound unpaired, as would be
needed to obtain a ligatable product from an equilibrating flap (Fig. 16.2a). The cleft formed
by the 3ᓉ-flap binding site physically blocks anything larger than a one nucleotide 3ᓉ-flap
being accommodated, consistent with biochemical experiments with substrates where the
3ᓉ-flap sugar moiety was modified (Kao et al. 2002). In conjunction with the 3ᓉ-flap binding
pocket, a conserved group of acidic residues (denoted as the acid block) in the proximity of
the 3ᓉ-flap binding pocket and presumably is present to prevent DNA moving beyond this
point. Both the 3ᓉ-flap binding pocket and the acid block are features that are present only in
FENs of the 5ᓉ-nuclease superfamily, suggesting this feature has evolved to enhance FEN
function. To a lesser extent, there are also interactions between residues of helix 3 and the
penultimate nucleotide of the 3ᓉ-flap strand. These residues are part of the hydrophobic
wedge that stabilizes the bent conformation of the two-way dsDNA junction by interacting
with the face of the last base pair created by the 3ᓉ-flap strand and template. In the free
protein structures (Sakurai et al. 2005), the residues involved in 3ᓉ-flap binding are
disordered (Fig. 16.3a), suggesting the 3ᓉ-flap pocket orders upon recognition and binding
of this nucleotide. The only structural feature of the 3ᓉ-flap that distinguishes it from all
other nucleotides in the upstream primer strand is the presence of a 3ᓉ-hydroxyl. Thus, it is
not surprising that the 3ᓉ-hydroxyl is used a key recognition feature by FEN.
16.3.3 Protein-Product Complex 5ƍ-Strand Interactions
Crystallization of hFEN1 in complex with a four nucleotide ‘quasi-equilibrating’ double flap
substrate resulted in an enzyme product complex where the dsDNA was still in complex
with the protein, consistent with the dsDNA product (Q) being a competitive inhibitor (Fig.
16.2f) (Finger et al. 2009). Unlike structures of hFEN1 in the absence of DNA, the residues
of the helical arch and the top of helix two are ordered in a gate-like conformation (Fig.
16.4g). Helix two and most of helix four form the posts of the gateway, whereas the upper
portion of helix 4 and all of helix 5 sits atop the two posts, and has been referred to as the
helical ‘cap’ (Fig. 16.3c,d). This nomenclature diverges from the previous arch or archway,
which does not include helix two. The helical gateway is 13 Å at its most narrow and is
located over the active site at the base of the arch. This region of the protein would not be
able to order if dsDNA is in the gateway. Although FENs can cleave flaps containing
dsDNA (Fig. 16.1i), a sufficient number of single-stranded nucleotides must be present
between the dsDNA in the flap and the two way-dsDNA junction to allow the helical
gateway to order around the ssDNA portion of the flap and to bring critical catalytic residues
into the active site. The helical cap sterically limits passage through the gateway to
substrates with free 5ᓉ terminus (i.e., no bubbles, bulges, etc.) (Tsutakawa et al. 2011).
Interestingly, the helical gateway is strongly conserved in the 5ᓉ-nuclease superfamily. The
cap, on the other hand, is conserved only in FEN1 and EXO1. GEN1 and XPG, which
cleave Holliday junctions and DNA bubbles, respectively, do not appear to have a cap
(Orans et al. 2011; Tsutakawa et al. 2011).
In the product complex, the nucleotide just to the 3ᓉ-side of the cleaved phosphate diester is
unpaired, with the 5ᓉ-phosphate monoester product interacting with the two divalent metal
ions in the active site. Comparison of the product and substrate complexes (Fig. 16.4c–f)
shows that two downstream dsDNA nucleotides 5ᓉ and 3ᓉ of the scissile phosphate must
unpair to enter the active site. Tyr40 of helix two stacks against the 3ᓉ-face of the base of the
unpaired nucleotide, thereby stabilizing the unpaired state (Fig. 16.4g). Two residues of
helix four, Lys93 and Arg100, interact with the terminal phosphate suggesting that these
residues are also important in stabilizing the unpaired state. These conserved residues were
also identified in a screen of toxic yeast rad27 mutants that had a dominant negative effect
on cell viability and growth (Storici et al. 2002). In DNA-free FEN structures where the
Finger et al. Page 7
Subcell Biochem. Author manuscript; available in PMC 2013 July 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
helical cap and gateway are disordered, Lys93 and Arg100 (or their equivalent homologues)
are not near the active site (Hos field et al. 1998b; Hwang et al. 1998; Sakurai et al. 2005).
Furthermore, evidence from studies of T5FEN suggests that Lys83, the equivalent of hFEN1
Lys93, acts as an electrophilic catalyst (Sengerova et al. 2010). Once flipped, the N-terminus
of Gly2 contacts the phosphate diester of the next nucleotide in the 5ᓉ-flap strand. The
trajectory of the phosphate backbone through the active site of the enzyme product complex
suggests that the substrate 5ᓉ-flap would traverse the helical gateway under the helical cap
(Tsutakawa et al. 2011) (Fig. 16.4e). This strongly suggests that a bind-then-thread
mechanism of action. However, this is still being debated (Patel et al. 2012).
16.3.4 Protein-Substrate Complex 5ƍ-Flap Strand Interactions
Overall, the protein-substrate and protein-product complexes share similar features in
binding, except for differences in the location of some downstream/flap strand primer
nucleotides and amino acid residues involved in the interaction with these two residues (Fig.
16.4d). Unlike the enzyme-product complex, the downstream 5ᓉ-flap strand of the enzyme
substrate complex is base paired to the template strand, and the scissile phosphate is in the
proximity of the active site, but not in contact with the critical active site metals or amino
acid residues. Despite not being in the active site, the protein-substrate complexes show that
binding of the dsDNA alone in this bent, non-contiguous manner results in the scissile
phosphate being placed within 5–8 Å of the active site in enzyme substrate complexes.
Moreover, the binding of a two-way dsDNA junction in this orientation is important to place
the scissile phosphate in the proximity of the active site. By allowing the structural features
of the placement of the scissile phosphate diester to be mainly with the template strand and
3ᓉ-flap rather than the 5ᓉ-flap strand itself may prevent inadvertent incision of ssDNA in the
5ᓉ-flap, creating products that would require DNA repair processes to correct the imprecise
cleavage. The lack of interaction with the 5ᓉ-flap strand allows cleavage of substrates
containing RNA or DNA in the 5ᓉ-flap or near the site of incision, which is consistent with
the fact that deletion of RNase H in yeast does not result in a significant mutator phenotype
(Qiu et al. 1999). The spacing between dsDNA binding regions of the protein formed by the
potassium ion/H2tH and at the DNA bend, which are approximately one helical turn apart, is
also critical to exclude incision of 3ᓉ-flaps. Using models, the spacing between dsDNA
binding sites is too wide for positioning a 5ᓉ-flap near the active site. FENs, therefore,
elegantly take advantage of the helical properties of two-way DNA junctions to position the
scissile phosphate diester close to the active site and to distinguish 5ᓉ-flap and 3ᓉ-flap
structures (Tsutakawa et al. 2011)
As noted above, one-fourth of the protein-DNA interactions are made by the helical gateway
of the protein and the nucleotides at the base of the 5ᓉ-flap around the scissile phosphate. In
the product complex, there is little direct interaction between the protein and the
downstream primer strand between the gateway and the potassium ion binding regions (Fig.
16.4a–d). Tyr40 in helix 2 stacks with the 5ᓉ-face of the base of the terminal 5ᓉ-flap strand
nucleotide, whereas another helix 2 residue, Ile44, contacts the 5ᓉ-face of the complimentary
nucleotide of the template strand. In addition, the scissile phosphate in the enzyme substrate
complex is in contact with the N-terminus (Gly2) (Fig. 16.4d), instead of the phosphate
diester 3ᓉ to the scissile phosphate in the enzyme-product complex (Fig. 16.4c). In the
paired substrate complex, the terminal base pair of the downstream dsDNA makes only one
of two possible H-bonds due to a pronounced base pair opening and stagger towards the
major groove. Although the DNA helical parameters of the upstream duplex conform to B-
DNA, the helical parameters of the downstream duplex differ. The dsDNA in contact with
the K+ ion and the H2tH motif conforms to B-DNA (Fig. 16.3c,d), but the six base pairs of
the downstream dsDNA nearest to the active site deviate from B-DNA parameters and
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become more like A-DNA (Fig. 16.4d). In this region, the nucleotides of the 5ᓉ-flap strand
DNA are less stacked (Tsutakawa et al. 2011).
16.3.5 Bind-Then-Thread or Bind-Then-Clamp
Despite this advance in our understanding of FEN substrate recognition, it is still unknown
whether the 5ᓉ-flap portion of the substrates is threaded through the arch consistent with the
bind-then-thread model (Xu et al. 2001), or if the flaps are instead clamped by the helical
arch (Chapados et al. 2004; Orans et al. 2011). Evidence for the bind-then-thread model
comes from the structure of T4 FEN in complex with a pseudo-Y substrate, which suggests
that the 5ᓉ-flap traverses the archway (Devos et al. 2007). However, in this structure, a
portion of the helical arch is not observed and the 5ᓉ-flap is not in the active site due to the
absence of the requisite divalent metals. The bind-then-thread model would be consistent
with the detrimental effects on incision activity with substrates where the 5ᓉ-flap has been
modified with streptavidin as passage through the helical arch would be blocked by the
addition of a molecule as large as tetrameric streptavidin (Gloor et al. 2010; Murante et al.
1995). However, because the structured helical arch is not large enough to accommodate
dsDNA, the ability to cleave a fold-back flap substrate is said to be more consistent with the
bind-then-clamp model (Finger et al. 2009). To counter this, the helical arch region in
several DNA-free FEN structures from several archaea and eukaryotes has been observed to
be unstructured (Fig. 16.3a) (Hosfield et al. 1998a; Hwang et al. 1998; Mase et al. 2009;
Sakurai et al. 2005). An unstructured arch is theoretically large enough to accommodate
double stranded DNA, and could then reorder around the ssDNA portion of the fold-back
flap structure (Tsutakawa et al. 2011). Thus, a bind-then-thread model, whereby substrates
containing dsDNA in the flap are threaded through an unstructured arch with subsequent
ordering after threading, is plausible (Patel et al. 2012).
16.3.6 Scissile Phosphate Placement: The DoubleNucleotide Unpairing Trap (DoNUT)
A disorder-to-order transition of the helical arch (gateway and cap) induced by DNA
binding is suggested by comparing DNA-bound hFEN1 structures with DNA-free hFEN1
structures that had previously been solved in complex with PCNA, where three hFEN1
molecules were bound to one PCNA homotrimer with each in a unique crystallographic
environment (Sakurai et al. 2005) (Fig. 16.5a,b). In all three DNA-free structures, the helical
gateway and cap, as well as the hydrophobic wedge of helix two were disordered (Fig.
16.3a). Furthermore, the catalytically critical residues in helix four (Lys93 and Arg100) and
helix two (Tyr40) were not correctly positioned. Thus, we proposed that the binding of the
3ᓉ-flap likely orders the hydrophobic wedge, which in turn leads to the ordering of the
helical gateway and cap. When ordered, Lys93 and Arg100 are poised in the active site (Fig.
16.4g,h). Because ordering has occurred without unpairing in the fully base-paired substrate
complexes, we propose that unpairing occurs after the ordering of the helical gateway.
Although base flipping can occur via movement through the major or minor groove
(Bouvier and Grubmuller 2007), the dinucleotide unpairing inferred by comparing enzyme-
substrate and enzyme-product complexes would likely occur via the major groove, because
as the minor groove pathway is blocked by the hydrophobic wedge of helix two. This is
consistent with the pronounced base pair opening and stagger towards the major groove in
the enzyme-substrate complex (Tsutakawa et al. 2011)
But what drives the unpairing of the DNA? It has been shown by von Hippel and co-workers
that nucleotides at ssDNA-dsDNA junctions are much more prone to spontaneous base
flipping than nucleotides farther away from the ssDNA-dsDNA junction (Jose et al. 2009).
Therefore, FENs may take advantage of this and simply capture the unpaired state.
Comparison of the helical parameters of the enzyme-substrate and enzyme-product
complexes shows that some of the distortions from B-DNA parameters in the downstream
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dsDNA of the enzyme-substrate complex are alleviated in the unpaired state of the enzyme-
product complex (i.e., returns to more B-DNA like parameters), thereby suggesting that
binding energy may also be used to promote the dinucleotide unpairing (Fersht 1999).
Regardless of whether the unpairing process is passive or is actively promoted by the
enzyme, the ability of FEN to capture the unpaired state is clearly demonstrated in the
product complex (Fig. 16.4c–h).
16.3.7 Cleavage of the Scissile Phosphate Diester: Active Site Structure
In the enzyme-product crystal structure, the active site of hFEN1 contains two samarium
(Sm3+) cations, which directly interact with the terminal phosphate of the product complex
(Fig. 16.4h,i). The Sm3+ ions are directly coordinated to FEN by four of the seven
carboxylate residues that are invariantly conserved in the 5ᓉ-nuclease superfamily active site
and occupy the same sites that Mg2+ is known to bind in the DNA-free hFEN1 protein
structures (Sakurai et al. 2005). Asp86, Glu160, Asp179, and Asp181 make inner sphere
contacts with the metal ions, with Glu160 acting as the crucial bridging residue between the
two metals. The other three conserved acidic residues in addition to a phenolic hydroxide
from a conserved tyrosine (Tyr234) make outer sphere contacts via water molecules. Using
a model of a ‘cleavage-competent’ enzyme-substrate complex based upon the enzyme-
product complex, we have proposed that the attacking water activated by the two divalent
metals hydrolyze the scissile phosphate diester bond in a manner similar to a mechanism
proposed for EndoIV (Garcin et al. 2008; Ivanov et al. 2007). However, others have
proposed a more traditional two divalent ion mechanism for cleavage, where the
nucleophilic water is activated by one of the two metal ions (Orans et al. 2011). More work
is necessary to distinguish which mechanism accurately describes hFEN1 catalysis and to
identify the mechanism responsible for activating the attacking nucleophile (Yang et al.
2006). Nevertheless, there is consensus that phosphate diester hydrolysis requires two ions,
in accordance with functional data (Syson et al. 2008)
16.4 Regulation of FEN1 Activity
The activity of FEN must be tightly controlled and coordinat with other components of the
DNA replication machinery. FEN has several protein-protein interaction partners that work
with FENs to achieve efficient and faithful copying of the DNA. FEN is also the target of
several post-translational modifications, adding a further level of control (Zheng et al.
2011b). FEN interacts with its partner proteins mainly through its C-terminal extension (Guo
et al. 2008a). This C-terminus has been implicated in DNA binding in vitro (Friedrich-
Heineken et al. 2003; Stucki et al. 2001), but may in fact be an artefact in vitro due to its role
of this region in mediating protein-protein interactions in vivo, which would interfere with
the ability to bind DNA (see Sect. 16.4.1). The C-terminus is likely disordered in the
absence of partner proteins; a disorder to order transition upon partner presence may allow
for multiple, simultaneous protein-protein interactions. Furthermore, FENs are sequestered
where necessary (e.g., nucleus and mitochondria), and evidence also suggests that even
subcellular as well as suborganellar location are regulated (Zheng et al. 2011b)
16.4.1 Protein-Protein Interactions
16.4.1.1 PCNA—Proliferating cell nuclear antigen (PCNA) is the major protein involved
in coordination of FEN recruitment and activity in the processing of Okazaki fragments.
PCNA is a trimeric ‘sliding clamp’ protein, localised at the sites of Okazaki fragment
maturation (see Chap. 15, this volume). PCNA binds and coordinates the action of pol  ?,
FEN and DNA ligase I (Beattie and Bell 2011; Burgers 2009). Each subunit of the
homotrimeric PCNA likely interacts with a particular protein. In support of this notion,
archaeal PCNA is a heterotrimer, with each member of the trimer having specificity for
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either pol  ?, FEN or ligase, suggesting a precise architecture in the maturation of Okazaki
fragments (Dionne et al. 2003). How a eukaryotic cell could ensure that each subunit of the
homotrimeric PCNA is loaded with a single pol  ?, FEN1, and ligase is unknown.
PCNA has been shown to interact with FEN1 in the absence of DNA (Wu et al. 1996)
through a PCNA binding motif QXX(I/L/M)XXF(F/Y) (Frank et al. 2001). Structural data
also shows that FENs utilize amino acid residues Thr336 to Leu356 in their C-terminus to
form two  ?-zippers ( ? A and  ?B) separated by a small  ? helix ( ?A) to interact with PCNA
(Fig. 16.5a–c) (Chapados et al. 2004; Sakurai et al. 2005). Disruption of FEN and PCNA
interactions by mutating Phe343 and Phe344 of FEN to alanine (FFAA) results in loss of
binding as determined using non-equilibrium binding assays, but does not affect FEN
nuclease activity in vitro or display gross phenotypes in yeast (Frank et al. 2001) However, a
homozygous FFAA mutation in mice results in newborn lethality and other phenotypes
indicative of poor replicative capacity (Zheng et al. 2007a). Furthermore, heterozygous
FFAA mice (i.e., FFAA/WT fen1) also show defects in Okazaki fragment maturation and an
increased rate of aneuploidy-associated cancers (Zheng et al. 2011a).
In the hFEN1-PCNA co-crystal structure, the various conformations of three hFEN1s were a
result of different torsion angles among four amino acid residues of hFEN1 (aa residues
333-336) (Sakurai et al. 2005) (Fig. 16.5a,b). This ‘hinge region’ (Fig. 16.5c) is conserved
among eukaryotic FENs. Using the recent hFEN1-product structure in combination with one
of the conformations in the FEN-PCNA structure, a model of how FEN and PCNA would
work together was generated (Fig. 16.5d). Although upstream dsDNA need only be as short
as 6 nts when studying FENs in vitro, the upstream dsDNA for a PCNA/FEN complex
would need to be 6 nts plus ᙺ15 base pairs to allow PCNA-DNA binding as well.
PCNA has been shown to stimulate in vitro FEN activity on static single-flap substrates
(Frank et al. 2001; Li et al. 1995; Sakurai et al. 2005). Furthermore, kinetic analyses have
shown that this PCNA stimulation occurs by facilitating FEN-DNA complex formation (i.e.,
decreases KM rather than increasing kcat (Hutton et al. 2009; Tom et al. 2000)). Because kcat
for FEN1 is a measure of enzyme-product release under MT conditions (Finger et al. 2009;
Williams et al. 2007), it is interesting that the addition of PCNA increases the affinity for
substrate but does not affect the rate of enzyme-product release. Obviously more work on
this is necessary to determine how PCNA can selectively enhance substrate binding without
slowing enzyme-product release.
16.4.1.2 RecQ Helicase Family Interactions—The RecQ helicase family members,
WRN (Werner syndrome ATP-dependent helicase) and BLM (Bloom syndrome protein),
are also key modulators of FEN activity. WRN co-localises with FEN at stalled replication
forks (Sharma et al. 2004), unwinding Holliday junctions and stimulating FEN cleavage in a
structure-dependent manner. WRN has also been shown to stimulate both FEN cleavage on
single-flap, EXO, and forked-gapped substrates (Sharma et al. 2004; Zheng et al. 2005).
FEN-WRN interactions are mediated by a 144 residue domain of WRN that has homology
to RecQ helicase, interacting with the terminal 18 residues of FEN's C-terminal domain
(Brosh et al. 2001; Guo et al. 2008a; Sharma et al. 2005). These residues are disordered in
the (hFEN1) 3-PCNA complex (Fig. 16.5c). WRN, unlike PCNA, purportedly stimulates
FEN by increasing its turnover of DNA substrates directly (Brosh et al. 2002). The WRN/
BLM binding site is adjacent to the PCNA binding site and should allow direct co-
ordination of activities by these partner proteins (Sharma et al. 2005). Both WRN and BLM
over-expression can rescue mutants lacking Dna2, indicating their ability to stimulate FEN
(Imamura and Campbell 2003; Sharma et al. 2004). WRN is also purportedly required for
nucleolar localisation of FEN (Guo et al. 2008b).
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16.4.2 Post-translational Modifications
Phosphorylation, methylation and acetylation also play a key role in modulating FEN
activity and localisation (Zheng et al. 2011b). FEN is phosphorylated at Ser187 in late S-
phase by the cyclin-dependent kinases Cdk1 and Cdk2, in partnership with cyclin A (Cdk1)
or cyclin E (Cdk2). Phosphorylation in vitro results in a decrease in nuclease activity, but
not DNA binding (Henneke et al. 2003). Phosphorylated FEN is unable to associate with
PCNA and possibly also abrogates interactions with other proteins like WRN (Zheng et al.
2011b). Interestingly, Ser187 is buried in both DNA–free and DNA–bound structures of
FEN (Sakurai et al. 2005; Tsutakawa et al. 2011). Thus, for kinases to phosphorylate FENs,
a conformational change will likely be necessary. PRMT5 methylates Arg192 (Guo et al.
2010), a residue whose side chain contacts DNA in the enzyme-product complex.
Methylation prevents phosphorylation, and has the opposite effect; addition of a methyl
group facilitates interaction with PCNA (Zheng et al. 2011b). Acetylation occurs on
multiple lysine residues of FEN both in vitro and in vivo (Choudhary et al. 2009; Hasan et
al. 2001). Acetylation in vitro of four lysines in the extreme C-terminus of the protein results
in a decrease in PCNA independent nuclease activity (Hasan et al. 2001). It is speculated
that acetylation could lead to blocking of the short flap pathway by retarding FEN activity,
leading to Okazaki fragment maturation by the long flap method involving Dna2
(Balakrishnan et al. 2009). The roles of Lys80 and Lys267 acetylation, which were
discovered in a genome-wide screen for acetylated proteins (Choudhary et al. 2009), remain
unclear. Lys80 is solvent exposed and interacts with PCNA residues in the hFEN1-PCNA
co-crystal structure (Sakurai et al. 2005); therefore, its modification could in fluence PCNA
interaction as well as other protein interaction partners. Lys267 interacts with the 3ᓉ-
terminus of the 5ᓉ-flap strand (Tsutakawa et al. 2011); therefore, the addition of an acetyl
group could regulate downstream dsDNA binding (Zheng et al. 2011b).
16.5 Handoff of DNA Intermediates
Although physical limitations such as diffusion and enzyme-product release sometimes limit
reaction rates in vitro, these limitations may not occur in vivo. To increase the efficiency of
metabolic processes, cells have overcome physical limitations by sequestering the requisite
proteins to their sites of action and channelling or handing-off intermediates from protein to
protein in the metabolic pathway, best exemplified by the multifunctional enzyme
tryptophan synthase (Yanofsky 1989). This channelling is important to cellular function as it
prevents the release of potentially reactive intermediates into solution and prevents the
establishment of enzyme-substrate equilibrium (Ovádi 1991). An analogy to DNA metabolic
pathways like Okazaki fragment maturation can be hypothesized, but rather than channelling
a small metabolite from one active site to another, the metabolic intermediate (i.e., DNA) is
passed from protein to protein. Although DNA nicks or flaps may not necessarily be reactive
intermediates, release of these species in vivo during Okazaki fragment maturation could
result in competition between ligation versus initiation of DNA repair pathways. Although
DNA repair pathways can usually faithfully replicate the DNA, these processes are not
perfect (e.g., unequal sister chromatid exchange in trinucleotide repeat regions resulting in
contractions and expansions). Thus, an attractive mechanism for the processing of Okazaki
fragment maturation is for intermediates to be efficiently passed between each protein in the
pathway with PCNA coordinating the overall process.
Although there is no direct biochemical evidence yet for this handoff model, support for it
does come from structural studies conducted on proteins involved in the pathway. Currently,
the best available polymerase structure in complex with downstream and upstream dsDNA
is a structure of pol  ? (Krahn et al. 2004). Although pol  ? is not involved in DNA
replication, it is involved in an analogous process of long-patch base excision repair (LP-
BER), (Robertson et al. 2009). Inspection of the pol  ?-DNA complex shows that the
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upstream and downstream dsDNA regions are bent ᙺ100° and that the base of the 5ᓉ-flap
and 3ᓉ-flap and upstream dsDNA duplex are in direct contact with the polymerase (Krahn et
al. 2004), and thus, would sterically clash with FENs (Fig. 16.5e). The only region exposed
for FENs to initially bind is the downstream dsDNA region. To access the 5ᓉ-and 3ᓉ-flaps,
FENs would first interact with the downstream dsDNA and would then displace the
polymerase (Tsutakawa et al. 2011). Because flaps in vivo can potentially migrate (Fig.
16.2e), the handoff of the substrate in this manner would prevent flaps from forming
structures that would need to be extensively remodelled before cleavage, thereby ensuring
efficient Okazaki fragment maturation. Still, at some point in this hypothetical transition
between the polymerase and FEN, the one nucleotide 3ᓉ-flap must bind the single nucleotide
binding pocket of FEN (Fig. 16.2e).
The structure of DNA ligase I in complex with DNA shows that the enzyme encircles the
nicked DNA using three domains: the DNA binding domain (DBD), adenylation domain
(AdD) and OB domain (OB) (see Chap. 17, this volume). It is known that the DBD is
essential for interaction with DNA substrates (Tomkinson et al. 2006). The DBD interacts
with the minor grooves on either side of the nick, whereas the OB fold interacts with the
major groove (Pascal et al. 2004). Inspection of the hFEN1-product complex shows that the
two minor grooves for DBD interaction are exposed (Fig. 16.5f). However, the product
DNA is bent in this structure unlike in the ligase I–DNA structure, where DNA is not bent in
order to align the termini for ligation. Despite this, the fact that the grooves necessary for
DBD interaction are exposed in the hFEN1-product complex provides further compelling
evidence for the handoff model, and suggests that hFEN1 and the DBD of ligase I could
bind DNA simultaneously.
In summary, consideration of the buried interfaces of the pol  ?, hFEN1 and ligase I in
complex with DNA shows that the choreography of handoff would be dictated by the
exposed regions of dsDNA. As such, it is not surprising that FENs have a tendency to retain
the product that is the substrate of the next step of the DNA metabolic pathway and simply
release the other upon cleavage. Such a handoff or ‘passing of the baton’ concept (Parikh et
al. 1999; Wilson and Kunkel 2000) is a simple but efficient way to envisage how the
efficiency of Okazaki fragment maturation can be increased beyond the physical limitations
of in vitro studies. The proteins necessary for the process are sequestered to the site of action
by PCNA, and the intermediates could be passed between one another (Beattie and Bell
2011; Burgers 2009). Although FENs show a remarkable non-sequence specific ability to
identify their substrate while preventing inadvertent activity on other DNA structures,
further work to determine how FEN interacts with its partner proteins is likely to be as
elegant as the structural and biochemical work to date that has dissected what we already
know about this remarkable enzyme.
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Fig. 16.1.
The role of FENs in lagging-strand DNA replication and various FEN substrates in vitro. (a)
Simplified diagram of the Okazaki fragment maturation (b–i) Various activities that can be
observed with FENs and model substrates in vitro. The grey image represents the protein
with the active site highlighted by the white circle to show how these activities are achieved.
(b–h) The strength of each activity is indicated by the order they are placed as illustrated by
the symbols between each. (i) Example of a forked-gap substrate. (j–l) Examples of double
flap constructs used in biochemical studies. Illustrations are labelled to (j) show how in vivo
Okazaki fragments correspond to in vitro substrates and (k) each region or (l) component of
the substrates are referred to as herein
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Fig. 16.2.
The importance of the 3ᓉ-flap in vitro and in vivo. Reactions on (a) double flaps result in all
dsDNA product being a ligatable nick, whereas (b) single flaps produce a minor product that
is a 1 nt gap. Examples of static (i.e., single conformation) double-(c) and single-(d) flaps
that are commonly used in vitro. (e) Flaps generated in replication are potentially migrating
flaps (equilibrating flaps) and can theoretically form multiple structures. Those labelled here
represent the two conformations important for polymerase and FENs. (f) Diagram of the
FEN reaction pathway on double-flap substrates deduced from studies of FENs to date. Note
this is only a model, and there may be more steps in the reaction pathway than illustrated.
The FEN enzyme (E) binds its substrate (S) to form an enzyme-substrate complex ([ES]). To
be able to cleave the substrate, the protein, DNA, or both have to change conformation to
create a cleavage competent complex ([ES]ᓊ). Upon cleavage, ssDNA (P) and dsDNA (Q)
products are created. The ssDNA (P) likely dissociates form the complex immediately upon
cleavage resulting in the enzyme-dsDNA product complex ([EQ]). The dissociation of [EQ]
results in nicked dsDNA and enzyme turnover. The rates (k) associated with each steps are
listed above or below the corresponding arrow: kon – bimolecular association (i.e.,
diffusion), koff – dissociation, kCC – conformational change, kRCC – reverse conformational
change, kchem – chemical catalysis, krelease – product dissociation, kPA – product association.
Note, kPA can be ignored when measuring initial rates of reaction. The macroscopic rate
constants commonly measured kinetically are above or below a bracket that encompasses
the rates that can in fluence the measured parameter. Because reactions with FEN have
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intermediates after initial [ES] formation, the KM is an overall dissociation constant for all
enzyme-bound species ([ES] + [ES]ᓊ + [EQ]). The turnover number (kcat) in WT FENs is
mainly a reflection of the slowest step (enzyme product release), but can be affected by
other first order rates in the reaction pathway. The second order rate constant (kcat/KM) for
WT is mainly a measure of diffusion (kon), but mutants of FENs can sometimes change and
represent anyone or some combination of steps within the bracket. The rate measured under
single turnover conditions can measure any rates after initial [ES] complex formation and
before [EQ] release and is a measure of some physical limitation such as conformational
change in WT FENs
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Fig. 16.3.
Comparison of DNA-free hFEN1 and DNA-bound hFEN1. Structures of (a) hFEN1 without
DNA and (b) hFEN1-product dsDNA with domain maps to highlight the ordering of the
helical gateway and cap. Filled circles and triangles represent  ?-helices and  ?-sheets,
respectively, and are numbered accordingly. The open circle represents a single helical turn
of 4 amino acids. The approximate locations of the seven acidic residues for divalent metal
sequestration and of the three amino acid residues responsible for coordination of the K+ ion
are represented by filled red stars and purple circle, respectively. Structures of the enzyme-
product (c) and enzymesubstrate (d) complexes with the protein illustrated as ribbon
diagrams with translucent surface representations. The DNA template, 5ᓉ-flap and 3ᓉ-flap
strand are shown in brown, yellow and purple, respectively
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Fig. 16.4.
FENs effectively utilize the helical properties of DNA to deliver the scissile phosphate to the
active site. Due to the spacing of the dsDNA binding regions and the bend induced on the
template strand of the two-way DNA junction, the template arc directs the 5ᓉ-flap strand
towards the active in both the enzyme product (a) and enzyme substrate (b) complexes. The
DNA strands and translucent surface representation of the protein are coloured as in Fig.
16.3. The two trivalent samarium ions (Sm3+) and the K+ ions are represented as cyan and
purple spheres, respectively. Looking at the DNA alone and representing sites of protein
contact to DNA by spheres, the product (c) and substrate (d) DNA are almost the same
except for important changes near the scissile phosphate. Note the lack of direct contacts in
the template arc region. Focussing on the downstream duplex region, comparison of the
product (e) and substrate (f) DNA near the active site shows that the two nucleotides have
unpaired for the scissile phosphate to interact with the catalytically important metal ions. In
addition, the Gly2 N-terminus (G2NT) interacts initially with the scissile phosphate diester
in the enzyme substrate complex (f), but interacts with the phosphate diester 3ᓉ to the
scissile phosphate in the enzyme-product complex (e). (g) View of the active site (coloured
as above) from the back of the helical gateway and helical cap to highlight some of the
catalytically important residues. (h) View of the complete hFEN1 active site that includes
the seven highly conserved carboxylates, two basic residues from helix four (Lys93 and
Arg100), and an aromatic stacking partner (Tyr40) from helix two. (i) View of the four
active site acidic residues (D86, E160, D179, and D181) and product complex unpaired base
phosphate monoester directly coordinating the Sm3+ metals (grey dashed lines)
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Fig. 16.5.
How FENs work with other proteins. (a) Structure of homotrimeric hPCNA in complex with
three subunits of hFEN1. The nuclease core domain is coloured as in Fig. 16.3. PCNA
subunits are shown as combined ribbon and transparent surface representation. The portion
of the extended C-terminus of hFEN1 that was observed in the crystal (residues 336–356)
and the regions important for interaction in PCNA are shown in yellow and magenta,
respectively. (b) Turning the structure 90° shows that the protein is positioned on one face
of the protein. (c) Closer view of the  ?A- ?A- ?B motif with schematic illustration below it
coloured as above. Alpha helices are represented as cylinders and arrows indicate the
position of the  ?-sheets. (d) Model of hFEN1 interacting with PCNA and DNA
simultaneously and coloured as above. (e) Comparison of the hFEN1 (blue) DNA (coloured
as above) structure with the pol  ?-DNA (Purple) structures shows that the only regions
available for FENs to initially contact in a handoff model is the downstream dsDNA binding
region. (f) Comparison of the DBD domain of ligase (green) and its known interaction site
(minor groove) in comparison to hFEN1 (blue) DNA product complex (coloured as above).
The groove necessary for DBD interaction is accessible. Below is a translucent surface
representation of the ligase DBD showing a steric clash between the DNA and the helical
cap of hFEN1. This steric interference may be the initial manner in which ligase facilitates
hFEN1 release of its product
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